$0.75
1.38% today
Nasdaq, Apr 02, 10:00 pm CET
ISIN
US09060C3097
Symbol
BKYI
Sector
Industry

BIO-key International, Inc. Stock price

$0.75
-0.27 26.48% 1M
-0.12 13.71% 6M
-0.96 56.15% YTD
-1.25 62.51% 1Y
-40.29 98.17% 3Y
-103.92 99.28% 5Y
-336.21 99.78% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
-0.01 1.38%
ISIN
US09060C3097
Symbol
BKYI
Sector
Industry

Key metrics

Market capitalization $2.38m
Enterprise Value $3.72m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.54
P/S ratio (TTM) P/S ratio 0.34
P/B ratio (TTM) P/B ratio 0.75
Revenue growth (TTM) Revenue growth -10.64%
Revenue (TTM) Revenue $6.93m
EBIT (operating result TTM) EBIT $-4.17m
Free Cash Flow (TTM) Free Cash Flow $-2.93m
Cash position $440.00k
EPS (TTM) EPS $-2.23
P/S forward 0.41
EV/Sales forward 0.49
Short interest 28.57%
Show more

Is BIO-key International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

BIO-key International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast BIO-key International, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast BIO-key International, Inc.:

Buy
100%

Financial data from BIO-key International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
6.93 6.93
11% 11%
100%
- Direct Costs 1.29 1.29
80% 80%
19%
5.97 5.97
317% 317%
86%
- Selling and Administrative Expenses 7.15 7.15
2% 2%
103%
- Research and Development Expense 2.66 2.66
11% 11%
38%
-3.69 -3.69
55% 55%
-53%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -4.17 -4.17
53% 53%
-60%
Net Profit -4.48 -4.48
47% 47%
-65%

In millions USD.

Don't miss a Thing! We will send you all news about BIO-key International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BIO-key International, Inc. Stock News

Neutral
Seeking Alpha
6 days ago
BIO-key International, Inc. (NASDAQ:BKYI ) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ET Company Participants William Jones - IR Michael DePasquale - Chairman and CEO Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's 2024 Fourth Quarter Conference Call.
Neutral
GlobeNewsWire
6 days ago
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin & Lower Operating Costs, Offsetting 11% Revenue Decrease From Business Transition.
Neutral
GlobeNewsWire
7 days ago
BIO-key (BKYI) Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time.
More BIO-key International, Inc. News

Company Profile

BIO-key International, Inc. is engaged in the development and market of fingerprint biometric technology and related security software solutions. It offers identification and verification solutions, such as personal inspection identification, passwords, tokens, smart cards, ID cards, PKI, credit card, passports, driver's licenses, and OTP or other form of possession or knowledge-based credentialing. It also delivers identification solutions and information services to commercial, government, law enforcement and prison markets. The company was founded on January 7, 1993 and is headquartered in Wall, NJ.

Head office United States
CEO Michael DePasquale
Founded 1993
Website www.bio-key.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today